Ligand Pharmaceuticals Statistics
Total Valuation
Azitra has a market cap or net worth of $2.83 million. The enterprise value is $92,123.
Important Dates
The next estimated earnings date is Tuesday, August 19, 2025, after market close.
| Earnings Date | Aug 19, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Azitra has 17.23 million shares outstanding. The number of shares has increased by 1,667.60% in one year.
| Current Share Class | 17.23M |
| Shares Outstanding | 17.23M |
| Shares Change (YoY) | +1,667.60% |
| Shares Change (QoQ) | +72.08% |
| Owned by Insiders (%) | 0.42% |
| Owned by Institutions (%) | 3.13% |
| Float | 17.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 151.15 |
| Forward PS | n/a |
| PB Ratio | 0.56 |
| P/TBV Ratio | 0.68 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 12.28 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.02, with a Debt / Equity ratio of 0.11.
| Current Ratio | 3.02 |
| Quick Ratio | 2.58 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -887.21 |
Financial Efficiency
Return on equity (ROE) is -208.50% and return on invested capital (ROIC) is -138.91%.
| Return on Equity (ROE) | -208.50% |
| Return on Assets (ROA) | -116.11% |
| Return on Invested Capital (ROIC) | -138.91% |
| Return on Capital Employed (ROCE) | -240.39% |
| Revenue Per Employee | $625 |
| Profits Per Employee | -$758,580 |
| Employee Count | 12 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Azitra has paid $9,031 in taxes.
| Income Tax | 9,031 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -69.64% in the last 52 weeks. The beta is -1.61, so Azitra's price volatility has been lower than the market average.
| Beta (5Y) | -1.61 |
| 52-Week Price Change | -69.64% |
| 50-Day Moving Average | 0.24 |
| 200-Day Moving Average | 0.34 |
| Relative Strength Index (RSI) | 27.62 |
| Average Volume (20 Days) | 989,682 |
Short Selling Information
The latest short interest is 1.13 million, so 6.54% of the outstanding shares have been sold short.
| Short Interest | 1.13M |
| Short Previous Month | 656,462 |
| Short % of Shares Out | 6.54% |
| Short % of Float | 6.59% |
| Short Ratio (days to cover) | 0.24 |
Income Statement
In the last 12 months, Azitra had revenue of $7,500 and -$9.10 million in losses. Loss per share was -$1.32.
| Revenue | 7,500 |
| Gross Profit | 7,500 |
| Operating Income | -11.12M |
| Pretax Income | -11.74M |
| Net Income | -9.10M |
| EBITDA | -10.99M |
| EBIT | -11.12M |
| Loss Per Share | -$1.32 |
Full Income StatementBalance Sheet
The company has $3.21 million in cash and $473,711 in debt, giving a net cash position of $2.73 million or $0.16 per share.
| Cash & Cash Equivalents | 3.21M |
| Total Debt | 473,711 |
| Net Cash | 2.73M |
| Net Cash Per Share | $0.16 |
| Equity (Book Value) | 4.41M |
| Book Value Per Share | 0.29 |
| Working Capital | 2.59M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$10.24 million and capital expenditures -$8,569, giving a free cash flow of -$10.24 million.
| Operating Cash Flow | -10.24M |
| Capital Expenditures | -8,569 |
| Free Cash Flow | -10.24M |
| FCF Per Share | -$0.59 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -148,318.41% |
| Pretax Margin | -121,252.41% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Azitra does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1,667.60% |
| Shareholder Yield | -1,667.60% |
| Earnings Yield | -322.21% |
| FCF Yield | -362.61% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | 559.40% |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 1, 2024. It was a reverse split with a ratio of 1:30.
| Last Split Date | Jul 1, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
Azitra has an Altman Z-Score of -18.23 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -18.23 |
| Piotroski F-Score | 1 |
